Arcellx (ACLX) Change in Acquisitions & Divestments (2022 - 2025)
Arcellx's quarterly Change in Acquisitions & Divestments came in at $108.2 million in Q4 2025, down 19.07% year-on-year from $133.7 million in Q4 2024, and up 5.66% quarter-over-quarter from $102.4 million in Q3 2025.
Arcellx has reported Change in Acquisitions & Divestments for 4 years, with the latest figure at $108.2 million in Q4 2025.
- For the quarter ending Q4 2025, Change in Acquisitions & Divestments fell 19.07% year-over-year to $108.2 million; the trailing twelve-month figure through Dec 2025 stood at $495.6 million (up 15.88% YoY), and the FY2025 full-year result was $495.6 million, up 15.88% from the prior year.
- Change in Acquisitions & Divestments for Q4 2025 stood at $108.2 million, up from $102.4 million in the prior quarter.
- The five-year high for Change in Acquisitions & Divestments was $167.8 million in Q2 2025, with the low at $16.8 million in Q1 2022.
- Average Change in Acquisitions & Divestments over 4 years is $86.9 million, with a median of $91.1 million recorded in 2023.
- Year-over-year, Change in Acquisitions & Divestments jumped 471.81% in 2023 and declined 19.07% in 2025.
- Tracing ACLX's Change in Acquisitions & Divestments over 4 years: stood at $60.7 million in 2022, then rose by 13.26% to $68.7 million in 2023, then surged by 94.63% to $133.7 million in 2024, then dropped by 19.07% to $108.2 million in 2025.
- The last three Change in Acquisitions & Divestments figures came in at $108.2 million (Q4 2025), $102.4 million (Q3 2025), and $167.8 million (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Arcellx | 6.48 Bn | 6.48 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 108.20 Mn |
| Dec 31, 2025 | 108.20 Mn |
| Sep 30, 2025 | 102.40 Mn |
| Sep 30, 2025 | 102.40 Mn |
| Jun 30, 2025 | 167.80 Mn |
| Jun 30, 2025 | 167.80 Mn |
| Mar 31, 2025 | 117.20 Mn |
| Mar 31, 2025 | 117.20 Mn |
| Dec 31, 2024 | 133.70 Mn |
| Dec 31, 2024 | 133.70 Mn |
| Sep 30, 2024 | 98.00 Mn |
| Sep 30, 2024 | 98.00 Mn |
| Jun 30, 2024 | 78.00 Mn |
| Jun 30, 2024 | 78.00 Mn |
| Mar 31, 2024 | 118.00 Mn |
| Mar 31, 2024 | 118.00 Mn |
| Dec 31, 2023 | 68.70 Mn |
| Dec 31, 2023 | 68.70 Mn |
| Sep 30, 2023 | 85.80 Mn |
| Sep 30, 2023 | 85.80 Mn |
| Jun 30, 2023 | 58.50 Mn |
| Jun 30, 2023 | 58.50 Mn |
| Mar 31, 2023 | 96.35 Mn |
| Mar 31, 2023 | 96.35 Mn |
| Dec 31, 2022 | 60.66 Mn |
| Dec 31, 2022 | 60.66 Mn |
| Sep 30, 2022 | 47.57 Mn |
| Sep 30, 2022 | 47.57 Mn |
| Jun 30, 2022 | 33.26 Mn |
| Jun 30, 2022 | 33.26 Mn |
| Mar 31, 2022 | 16.85 Mn |
| Mar 31, 2022 | 16.85 Mn |